🇺🇸 FDA
Pipeline program

CF 102

CF102-103HCV

Phase 2 small_molecule completed

Quick answer

CF 102 for Chronic Hepatitis C is a Phase 2 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Can-Fite BioPharma
Indication
Chronic Hepatitis C
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials